![]() |
|
|
Am. J. Biomed. Sci. 2012, 4(2), 111-122; doi: 10.5099/aj120200111 |
Short-term Intake of Calcium Fructoborate Improves WOMAC and McGill Scores and
Beneficially Modulates Biomarkers Associated with Knee Osteoarthritis: A Pilot
Clinical Double-blinded Placebo-controlled Study |
Tania Reyes-Izquierdo1, Boris Nemzer2*, Ana
Elizabeth Gonzalez 3, Qing Zhou1, Ruby Argumedo1,
Cynthia Shu1, and Zb Pietrzkowski1 |
1Applied BioClinical,
Inc., |
2VDF FutureCeuticals,
Inc, |
3NutraClinical
Inc., |
*Corresponding
Author |
Boris Nemzer |
Director of Research and Development |
FutureCeuticals, Inc. |
|
|
Email: bnemzer@vandrunen.com |
Abstract Knee osteoarthritis (OA) is a common degenerative joint
disease which contributes significantly to the burden of physical disability.
Conventional management of OA mainly focuses on relief of symptoms using
analgesics and non-steroidal anti-inflammatory drugs (NSAIDs). Some dietary
supplements have shown some potency to reduce symptoms associated with OA
conditions. Calcium Fructoborate (commercially marketed under the trade name FruiteX-B®),
is a naturally occurring borate complex as first described by Patrick Brown [1]. For this study, FruiteX-B® was characterized by NMR and data from solid and
liquid-state 11B NMR have been obtained and compared against boric acid
and fructose for quality purposes. In this study, FruiteX-B®
was tested for fourteen days at a serving of 108 mg twice a day on
subjects diagnosed with minor osteoarthritis conditions of the knees by CT
scan. FruiteX-B® was well tolerated by all study
subjects with no reports of adverse effect and resulted in several positive
outcomes. On Day 14, WOMAC and McGill indexes were reduced by an average 29% and 14% respectively over Day 1
pre-ingestion values. Blood level of C-Reactive Protein (CRP) in 7 out of 10
subjects was found reduced up to 37% compared to Day 1 baseline levels.
Interestingly, the study also showed that blood level of endogenous 1, 25(OH)
vitamin D was increased more than 19% compared to baseline. However,
differences in 25(OH) vitamin D were not observed. These results indicate that FruiteX-B® at a serving as low as 108mg twice a day
provides significant benefits to people experiencing conditions associated with
knee osteoarthritis. On the basis of these results, a larger clinical efficacy
study is highly justified. |
Keywords: Calcium Fructoborate (FruiteX-B®), knee
osteoarthritis, WOMAC Index, McGill
Index, C-Reactive Protein, vitamin D. Download the full article (PDF)
|
Publisher | Missions and Scope | Editorial Board | Instructions for Authors |
© American Journal of Biomedical Sciences 2007-2021. All Rights Reserved. |